Publications

5491 Results

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Authors
C Chen;G Zirpoli;S McCann;W Barlow;GT Budd;L Pusztai;NL Henry;A Godwin;A Thompson;C Ambrosone;K Stringer;D Hertz
Journal / Conference
Journal of the National Comprehensive Cancer Network Nov;21(11):1172-1180.e3
Year
2023
Research Committee(s)
Breast
PMID
PMID37935109
PMC
PMC10976748
Study Number(s)
S0221

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.

Authors
L Dillon;J Higgins;H Nasif;M Othus;L Beppu;T Smith;E Schmidt;C Valentine;J Salk;B Wood;J Radich;C Hourigan
Journal / Conference
Haematologica Aug 3; doi: 10.3324/haematol.2023.283520 Online ahead of print
Year
2023
Research Committee(s)
Leukemia
PMID
PMID:37534515
PMC
PMC10081409
Study Number(s)
S0106

Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing

Authors
DL Hershman;A Bansal;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;S Sullivan;G Lyman;S Ramsey
Journal / Conference
JCO Oncology Practice Dec;19(12):1160-1167
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37788414
PMC
PMC10732502
Study Number(s)
S1415CD

Impact of Treatment Experience on Patient Knowledge of Colony Stimulating Factors Among Patients Receiving Cancer Chemotherapy: Evidence from S1415CD, A Large Pragmatic Trial

Authors
G Lyman;A Bansal;S Sullivan;K Arnold;W Barlow;D Hershman;T Lad;S Ramsey
Journal / Conference
Supportive Care in Cancer Sep 28;31(10):598
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37770704
PMC
PMC11060514
Study Number(s)
S1415CD

Sociodemographic risk factors and prediction of aromatase inhibitor non-adherence in women with breast cancer enrolled in SWOG S1105

Authors
DL Hershman;A Moseley;K Arnold;J Gralow;A Neugut;S Ramsey;NL Henry;J Unger
Journal / Conference
SABCS (San Antonio Breast Cancer Symposium, December 5-9, San Antonio, TX), Poster Spotlight Discussion, PS04-08
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

Long-term Follow for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;J Park;M Wieduwilt;D Jeyakumar;G Yaghmour;E Atallah;A Gerds;S O'Brien;J Liesveld;M Othus;M Litzow;R Stone;E Sharon;C Yeung;J Radich;H Erba
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Leukemia
Study Number(s)
S1318

Minimal residual disease (MRD) status predicts outcomes in patients with follicular lymphoma (FL) treated with chemo-immunotherapy on SWOG S0016 study

Authors
A Danilov;H Li;M Shadman;L Rimsza;A Zebari;S Smith;M LeBlanc;J Friedberg;C Carlson;J Song
Journal / Conference
ASH Annual Meeting (Dec 9-12,2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Class III obesity is associated with worse overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203

Authors
MY Zhang;M Othus;K McMillen;H Erba;G Garcia-Manero;J Pagel;M Sorro;M-E Percival
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Leukemia
Study Number(s)
S1203

SWOG S1931 (PROBE): Phase III randomized trial of Immune checkpoint inhibitor (ICI) combination regimen with or without Cytoreductive Nephrectomy (CN) in Advanced Renal Cancer [NCT04510597]

Authors
H Kim;C Tangen;U Vaishampayan;A Tripathi;B Shuch;S Pal;P Barata;A Tan;L Esfeller;P Lara;A Sanchez;SP Lerner;IM Thompson
Journal / Conference
SUO (Society of Urologic Oncology) (Nov 28-Dec 1, Washington, DC), TIPS, poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1931

Progression-Free Survival (PFS) and toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Authors
S Castellino;H Li;A Herrera;A Punnett;M LeBlanc;F Keller;R Drachtman;A Lamble;C Forlenza;A Doan;S Rutherford;A Evens;D Hodgson;S Parsons;R Little;M Smith;J Song;S Smith;JW Friedberg;K Kelly
Journal / Conference
ASH Annual Meeting (Dec 9-12, 2023, San Diego), oral
Year
2023
Research Committee(s)
Lymphoma
Study Number(s)
S1826